Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T Cells

Tara B Reid,Charmie Godornes,Victoria L Campbell,Kerry J Laing,Lauren C Tantalo,Alloysius Gomez,Thepthara N Pholsena,Nicole A P Lieberman,Taylor M Krause,Victoria I Cegielski,Lauren A Culver,Nhi Nguyen,Denise Q Tong,Kelly L Hawley,Alexander L Greninger,Lorenzo Giacani,Caroline E Cameron,Julia C Dombrowski,Anna Wald,David M Koelle
DOI: https://doi.org/10.1093/infdis/jiae245
2024-08-16
Abstract:Background: Histologic and serologic studies suggest the induction of local and systemic Treponema pallidum-specific CD4+ T-cell responses to T. pallidum infection. We hypothesized that T. pallidum-specific CD4+ T cells are detectable in blood and in the skin rash of secondary syphilis and persist in both compartments after treatment. Methods: Peripheral blood mononuclear cells collected from 67 participants were screened by interferon-γ (IFN-γ) ELISPOT response to T. pallidum sonicate. T. pallidum-reactive T-cell lines from blood and skin were probed for responses to 89 recombinant T. pallidum antigens. Peptide epitopes and HLA class II restriction were defined for selected antigens. Results: We detected CD4+ T-cell responses to T. pallidum sonicate ex vivo. Using T. pallidum-reactive T-cell lines we observed recognition of 14 discrete proteins, 13 of which localize to bacterial membranes or the periplasmic space. After therapy, T. pallidum-specific T cells persisted for at least 6 months in skin and 10 years in blood. Conclusions: T. pallidum infection elicits an antigen-specific CD4+ T-cell response in blood and skin. T. pallidum-specific CD4+ T cells persist as memory in both compartments long after curative therapy. The T. pallidum antigenic targets we identified may be high-priority vaccine candidates.
What problem does this paper attempt to address?